All posts tagged
French Biotech Announces Positive Phase I Results in T-cell Lymphoma
French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug
How is Biotech Transforming Pharma’s R&D Model?
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
French Biotech’s Checkpoint Inhibitor Fails Phase II Leukemia Trial
A Combination of Checkpoint Inhibitors triggers new Milestone Payment
How is European Immuno-Oncology fighting Blood Cancer?
These EU Biotechs presented groundbreaking results at World Biggest Cancer Meeting
3 French Bioentrepreneurs are Awarded for Being Stubborn
Money Money Money for Immuno-Oncology: BMS Joins up with a Top German VC
Innate Pharma receives $5M from its Monster-deal with BMS
Biotechs outperformed in the top 40 European Tech Companies
Labiotech UG, All Rights Reserved -
Send this to a friend